This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
So often, promising medical studies fan enthusiasm among people suffering from a vexing illness, only to leave them waiting months or years while the new drug or medical device clears regulatory hurdles. Not this time: A trio of drugs proved significantly better at slowing the growth of an aggressive type of breast cancer than the conventional drug regimen, according to a study led by Mayo Clinic Jacksonville researchers. And patients don't have to wait to try it.
We care about your feedback. Let us know how we can improve your CancerCompass experience.